OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 105 citing articles:

TRIM6 Reduces Ferroptosis and Chemosensitivity by Targeting SLC1A5 in Lung Cancer
Ying Zhang, Ping Dong, Nian Liu, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 19

Autophagy Suppresses Ferroptosis by Degrading TFR1 to Alleviate Cognitive Dysfunction in Mice with SAE
Li-Xia Du, You Wu, Qi Jia, et al.
Cellular and Molecular Neurobiology (2023)
Closed Access | Times Cited: 19

Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis
Wenjing Yu, Yuehuai Hu, Zhiping Liu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4875-4892
Open Access | Times Cited: 16

Cell death regulation in myocardial toxicity induced by antineoplastic drugs
Xue Yu, Yan Yang, Tianzuo Chen, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 15

The crosslinks between ferroptosis and autophagy in asthma
Xiaodi Lv, Weifeng Tang, Jingjing Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15

Ferroptosis: A novel therapeutic target of natural products against doxorubicin-induced cardiotoxicity
Xiaojiao Yi, Qi Wang, Mengjie Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117217-117217
Open Access | Times Cited: 5

The Dual Function of Autophagy in Doxorubicin-induced Cardiotoxicity: Mechanism and Natural products
Nannan Tan, Hanwen Luo, Weili Li, et al.
Seminars in Cancer Biology (2025)
Closed Access

Programmed cardiomyocyte death in myocardial infarction
Hao Wu, Qi Lan, Yi-Xiang He, et al.
APOPTOSIS (2025)
Closed Access

Curcumin attenuates myocardial ischemia‑reperfusion‑induced autophagy‑dependent ferroptosis via Sirt1/AKT/FoxO3a signaling
Shi-Tao Zhao, Zhi-Cong Qiu, Zhi‐Qiang Xu, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access

Glutathione reductase underlies the stability of mutant p53 by antagonizing protein glutathionylation
Liansheng Wang, Suqin Zhong, Xiaolin Fan, et al.
Redox Biology (2025), pp. 103522-103522
Open Access

Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway
Xiaoqi Li, Xin Wang, Binyu Wang, et al.
Phytomedicine (2022) Vol. 99, pp. 154027-154027
Closed Access | Times Cited: 25

The SPATA2/CYLD pathway contributes to doxorubicin-induced cardiomyocyte ferroptosis via enhancing ferritinophagy
Yuan-Jing Zhou, Dan-Qing Duan, Li-Qun Lu, et al.
Chemico-Biological Interactions (2022) Vol. 368, pp. 110205-110205
Closed Access | Times Cited: 25

Can Polyphenols Inhibit Ferroptosis?
Marija Lesjak, Nataša Simin, Surjit Kaila Srai
Antioxidants (2022) Vol. 11, Iss. 1, pp. 150-150
Open Access | Times Cited: 23

Scutellarin attenuates doxorubicin-induced oxidative stress, DNA damage, mitochondrial dysfunction, apoptosis and autophagy in H9c2 cells, cardiac fibroblasts and HUVECs
Li Zhou, Yonglong Han, Quanjun Yang, et al.
Toxicology in Vitro (2022) Vol. 82, pp. 105366-105366
Closed Access | Times Cited: 23

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
Huiyan Sun, Dandan Chen, Wenjing Xin, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14

Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress
Jiayan Zhang, Yafang Zha, Yuheng Jiao, et al.
Toxicology (2023) Vol. 485, pp. 153426-153426
Closed Access | Times Cited: 13

Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson’s disease in a Drosophila model
Yanzhou Xia, Hongyan Wang, Zhongwen Xie, et al.
Free Radical Biology and Medicine (2023) Vol. 211, pp. 63-76
Closed Access | Times Cited: 13

Beyond Mortality: Exploring the Influence of Plant Phenolics on Modulating Ferroptosis—A Systematic Review
Nemanja Živanović, Marija Lesjak, Nataša Simin, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 334-334
Open Access | Times Cited: 4

Therapeutic Effects of Melatonin in the Regulation of Ferroptosis: A Review of Current Evidence
Mohammad Hossein Pourhanifeh, Azam Hosseinzadeh, Fereshteh Koosha, et al.
Current Drug Targets (2024) Vol. 25, Iss. 8, pp. 543-557
Closed Access | Times Cited: 4

Cardioprotective potentials of myricetin on doxorubicin-induced cardiotoxicity based on biochemical and transcriptomic analysis
Jaili Li, Ting Luo, Yao Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116748-116748
Open Access | Times Cited: 4

CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes
Dan Liu, Xiaoli Cheng, Han-Lin Wu, et al.
Redox Biology (2024) Vol. 75, pp. 103293-103293
Open Access | Times Cited: 4

P62-autophagic pathway degrades SLC7A11 to regulate ferroptosis in doxorubicin-induced cardiotoxicity
Jihong Wang, Hong Yi, Juxiang Li, et al.
Life Sciences (2024) Vol. 356, pp. 122981-122981
Closed Access | Times Cited: 4

Sarmentosin alleviates doxorubicin-induced cardiotoxicity and ferroptosis via the p62-Keap1-Nrf2 pathway
Zhihui Lin, Chang Wu, Dongyan Song, et al.
Redox Report (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4

Scroll to top